Levels of Inflammatory Markers in the Treatment of StrokeāAn SPS3 Ancillary Study "LIMITS"
Completed
Phase N/A Results N/AView Trial Locations
Recruitment
- Enrollment: 1,244
- Gender: All
- Minimum Age: 30 Years
- Accepts Healthy Volunteers: No
- 48 locations, 7 countries
Principal Investigator
- Mitchell S.V. Elkind, MD, MS, FAAN
Columbia University
- Oscar Benavente, MD
UTHSC San Antonio (SPS3 Principal Investigator)
- Robert Hart, MD
UTHSC San Antonio (SPS3 Principal Investigator)